Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies
Crossref DOI link: https://doi.org/10.1007/s40121-017-0162-1
Published Online: 2017-07-10
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilson, Samuel E.
Graham, Donald R.
Wang, Whedy
Bruss, Jon B.
Castaneda-Ruiz, Bibiana
Funding for this research was provided by:
Theravance Biopharma, Inc.